556 related articles for article (PubMed ID: 16774108)
61. Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea.
Gach JE; Berth-Jones J
J Dermatolog Treat; 2003 Dec; 14(4):226-8. PubMed ID: 14660269
[TBL] [Abstract][Full Text] [Related]
62. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
Wozel G; Vitez L
Acta Derm Venereol; 2008; 88(2):169-70. PubMed ID: 18311451
[No Abstract] [Full Text] [Related]
63. Biologic therapy in erythrodermic and pustular psoriasis.
Levin EC; Debbaneh M; Koo J; Liao W
J Drugs Dermatol; 2014 Mar; 13(3):342-54. PubMed ID: 24595581
[TBL] [Abstract][Full Text] [Related]
64. Sequential use of infliximab and etanercept in generalized pustular psoriasis.
Weisenseel P; Prinz JC
Cutis; 2006 Sep; 78(3):197-9. PubMed ID: 17036664
[TBL] [Abstract][Full Text] [Related]
65. Humanized monoclonal anti-CD25 antibody as a novel therapeutic option in HIV-associated psoriatic erythroderma.
Dichmann S; Mrowietz U; Schöpf E; Norgauer J
J Am Acad Dermatol; 2002 Oct; 47(4):635-6. PubMed ID: 12271320
[No Abstract] [Full Text] [Related]
66. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
67. Ustekinumab (Stelara) for psoriasis.
Med Lett Drugs Ther; 2010 Jan; 52(1330):7-8. PubMed ID: 20208473
[No Abstract] [Full Text] [Related]
68. [What are the objectives of moderate to severe psoriasis treatment?].
Ortonne JP
Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S281-4. PubMed ID: 18721665
[TBL] [Abstract][Full Text] [Related]
69. Response of severe psoriasis to infliximab.
Mang R; Stege H; Ruzicka T; Krutmann J
Dermatology; 2002; 204(2):156-7. PubMed ID: 11937748
[No Abstract] [Full Text] [Related]
70. Infliximab treatment of psoriasis in supervised infusion centers: case management experience.
Campos Muñoz L; de Unamuno Bustos B; Herranz Pinto P; El Ahmed HH; Ruiz-Villaverde R; Taberner Ferrer R
Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S17-24. PubMed ID: 24777572
[TBL] [Abstract][Full Text] [Related]
71. Juvenile generalized pustular psoriasis.
Xiao T; Li B; He CD; Chen HD
J Dermatol; 2007 Aug; 34(8):573-6. PubMed ID: 17683391
[TBL] [Abstract][Full Text] [Related]
72. Erythroderma in a patient taking acitretin for plaque psoriasis.
Ahdout J; Mandel H; Chiu M
J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
[TBL] [Abstract][Full Text] [Related]
73. Erythrodermic psoriasis peculiarly sparing anti-TNF injection sites in a patient with secondary loss of efficacy.
Kapoor DM; Tan KW
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28976682
[No Abstract] [Full Text] [Related]
74. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
[No Abstract] [Full Text] [Related]
75. Infliximab in recalcitrant generalized pustular arthropatic psoriasis.
Vieira Serrão V; Martins A; Lopes MJ
Eur J Dermatol; 2008; 18(1):71-3. PubMed ID: 18086593
[TBL] [Abstract][Full Text] [Related]
76. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
Wozel G; Vitéz L; Meurer M
Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
[TBL] [Abstract][Full Text] [Related]
77. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Menter A; Feldman SR; Weinstein GD; Papp K; Evans R; Guzzo C; Li S; Dooley LT; Arnold C; Gottlieb AB
J Am Acad Dermatol; 2007 Jan; 56(1):31.e1-15. PubMed ID: 17097378
[TBL] [Abstract][Full Text] [Related]
78. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab.
Bartke U; Venten I; Kreuter A; Gubbay S; Altmeyer P; Brockmeyer NH
Br J Dermatol; 2004 Apr; 150(4):784-6. PubMed ID: 15099388
[No Abstract] [Full Text] [Related]
79. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
Mekkes JR; Bos JD
Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
[TBL] [Abstract][Full Text] [Related]
80. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.
Campbell LS; Chevalier M; Levy RA; Rhodes A
Pediatr Dermatol; 2012; 29(1):101-4. PubMed ID: 21995486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
